Global Immunoassay Market
Global Immunoassay Market

Immunoassay Comprehensive Study by Type (Reagents and Kits, Analyzers, Software and Services), Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology and Blood Screening, Autoimmune Disorders, Others), Platform (Chemiluminescence Immunoassays, Fluorescence Immunoassays, Colorimetric Immunoassays, Radioimmunoassays, Other), Technology (Enzyme-Linked Immunosorbent Assays, Rapid Tests, Enzyme-Linked Immunospot, Western Blotting, Immuno-Pcr, Other) Players and Region - Global Market Outlook to 2024

Immunoassay Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

May 2019 Edition 203 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Immunoassay is a highly selective bioanalytical method that measures the presence or concentration of analytes ranging from small molecules to macromolecules in a solution through the use of an antibody or an antigen as a biorecognition agent. It helps to detect the antigens of viruses, bacteria, parasites, hormones and markers that are specific to a certain disease. It is useful in various bioanalytical settings such as clinical diagnostics, biopharmaceutical analysis, environmental monitoring, security and food testing. A substantial rise in the cases of infectious and chronic disease and the rise in the use of immunoassays in oncology are likely as the main factors that are projected to support the development of the market in the coming years. Moreover, the high development in biopharmaceutical and biotechnology industries is another factor that is predicted to create potential growth opportunities over the coming years.

The market study is being classified by Type (Reagents and Kits, Analyzers and Software and Services), by Application (Infectious Disease, Endocrinology, Oncology, Cardiology, Hematology and Blood Screening, Autoimmune Disorders and Others) and major geographies with country level break-up.

Bio-Rad Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Siemens Healthineers (Germany), Becton, Dickinson and Company (United States), Danaher Corporation (United States), bioMérieux Inc. (France), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan) and Abcam plc. (United Kingdom) are some of the key players profiled in the study.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Immunoassay market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Immunoassay market by Type, Application and Region.

On the basis of geography, the market of Immunoassay has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Platform, the sub-segment i.e. Chemiluminescence Immunoassays will boost the Immunoassay market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Enzyme-Linked Immunosorbent Assays will boost the Immunoassay market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growth in the Biotechnology and Biopharmaceutical Industries
  • Rising Incidence Rate of Chronic and Infectious Diseases
  • Increasing Adoption of Immunoassay Based Testing

Market Trend
  • Technological Advancements in Immunoassay Instruments

Restraints
  • Stringent Regulatory Requirements for Immunoassay Instrument Approval
  • High Prices Of the Immunoassay Systems

Opportunities
  • Growth Opportunities in the Emerging Countries
  • Rising Geriatric Population

Challenges
  • Technical Difficulties during Testing


Market Leaders and their expansionary development strategies
On 15th December 2017, Siemens Healthineers acquired Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of diagnostics tests. By introducing FTD products to its molecular diagnostics portfolio, Siemens Healthineers is further investing in precision medicine and better patient experience through solutions that eliminate the need for repeat diagnostic testing, reducing time and improving patient outcomes.
On 10th April 2019, Thermo Fisher Scientific, the world leader in serving science, launched Immunoassay for Kratom Alkaloid Mitragynine Screening. It’s the newest drugs of abuse test supporting calibrators and controls.


Key Target Audience
Pharmaceutical and Biotechnology Companies, Hospitals, Clinical Laboratories, Blood Banks, Research and Academic Laboratories and End-user

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Reagents and Kits
  • Analyzers
  • Software and Services
By Application
  • Infectious Disease
  • Endocrinology
  • Oncology
  • Cardiology
  • Hematology and Blood Screening
  • Autoimmune Disorders
  • Others
By Platform
  • Chemiluminescence Immunoassays
  • Fluorescence Immunoassays
  • Colorimetric Immunoassays
  • Radioimmunoassays
  • Other

By Technology
  • Enzyme-Linked Immunosorbent Assays
  • Rapid Tests
  • Enzyme-Linked Immunospot
  • Western Blotting
  • Immuno-Pcr
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in the Biotechnology and Biopharmaceutical Industries
      • 3.2.2. Rising Incidence Rate of Chronic and Infectious Diseases
      • 3.2.3. Increasing Adoption of Immunoassay Based Testing
    • 3.3. Market Challenges
      • 3.3.1. Technical Difficulties during Testing
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Immunoassay Instruments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunoassay, by Type, Application, Platform, Technology and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Immunoassay (Value)
      • 5.2.1. Global Immunoassay by: Type (Value)
        • 5.2.1.1. Reagents and Kits
        • 5.2.1.2. Analyzers
        • 5.2.1.3. Software and Services
      • 5.2.2. Global Immunoassay by: Application (Value)
        • 5.2.2.1. Infectious Disease
        • 5.2.2.2. Endocrinology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Cardiology
        • 5.2.2.5. Hematology and Blood Screening
        • 5.2.2.6. Autoimmune Disorders
        • 5.2.2.7. Others
      • 5.2.3. Global Immunoassay by: Platform (Value)
        • 5.2.3.1. Chemiluminescence Immunoassays
        • 5.2.3.2. Fluorescence Immunoassays
        • 5.2.3.3. Colorimetric Immunoassays
        • 5.2.3.4. Radioimmunoassays
        • 5.2.3.5. Other
      • 5.2.4. Global Immunoassay by: Technology (Value)
        • 5.2.4.1. Enzyme-Linked Immunosorbent Assays
        • 5.2.4.2. Rapid Tests
        • 5.2.4.3. Enzyme-Linked Immunospot
        • 5.2.4.4. Western Blotting
        • 5.2.4.5. Immuno-Pcr
        • 5.2.4.6. Other
      • 5.2.5. Global Immunoassay Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Immunoassay: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Siemens Healthineers (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton, Dickinson and Company (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioMérieux Inc. (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abbott Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sysmex Corporation (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abcam plc. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunoassay Sale, by Type, Application, Platform, Technology and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Immunoassay (Value)
      • 7.2.1. Global Immunoassay by: Type (Value)
        • 7.2.1.1. Reagents and Kits
        • 7.2.1.2. Analyzers
        • 7.2.1.3. Software and Services
      • 7.2.2. Global Immunoassay by: Application (Value)
        • 7.2.2.1. Infectious Disease
        • 7.2.2.2. Endocrinology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Cardiology
        • 7.2.2.5. Hematology and Blood Screening
        • 7.2.2.6. Autoimmune Disorders
        • 7.2.2.7. Others
      • 7.2.3. Global Immunoassay by: Platform (Value)
        • 7.2.3.1. Chemiluminescence Immunoassays
        • 7.2.3.2. Fluorescence Immunoassays
        • 7.2.3.3. Colorimetric Immunoassays
        • 7.2.3.4. Radioimmunoassays
        • 7.2.3.5. Other
      • 7.2.4. Global Immunoassay by: Technology (Value)
        • 7.2.4.1. Enzyme-Linked Immunosorbent Assays
        • 7.2.4.2. Rapid Tests
        • 7.2.4.3. Enzyme-Linked Immunospot
        • 7.2.4.4. Western Blotting
        • 7.2.4.5. Immuno-Pcr
        • 7.2.4.6. Other
      • 7.2.5. Global Immunoassay Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunoassay: by Type(USD Million)
  • Table 2. Immunoassay Reagents and Kits , by Region USD Million (2013-2018)
  • Table 3. Immunoassay Analyzers , by Region USD Million (2013-2018)
  • Table 4. Immunoassay Software and Services , by Region USD Million (2013-2018)
  • Table 5. Immunoassay: by Application(USD Million)
  • Table 6. Immunoassay Infectious Disease , by Region USD Million (2013-2018)
  • Table 7. Immunoassay Endocrinology , by Region USD Million (2013-2018)
  • Table 8. Immunoassay Oncology , by Region USD Million (2013-2018)
  • Table 9. Immunoassay Cardiology , by Region USD Million (2013-2018)
  • Table 10. Immunoassay Hematology and Blood Screening , by Region USD Million (2013-2018)
  • Table 11. Immunoassay Autoimmune Disorders , by Region USD Million (2013-2018)
  • Table 12. Immunoassay Others , by Region USD Million (2013-2018)
  • Table 13. Immunoassay: by Platform(USD Million)
  • Table 14. Immunoassay Chemiluminescence Immunoassays , by Region USD Million (2013-2018)
  • Table 15. Immunoassay Fluorescence Immunoassays , by Region USD Million (2013-2018)
  • Table 16. Immunoassay Colorimetric Immunoassays , by Region USD Million (2013-2018)
  • Table 17. Immunoassay Radioimmunoassays , by Region USD Million (2013-2018)
  • Table 18. Immunoassay Other , by Region USD Million (2013-2018)
  • Table 19. Immunoassay: by Technology(USD Million)
  • Table 20. Immunoassay Enzyme-Linked Immunosorbent Assays , by Region USD Million (2013-2018)
  • Table 21. Immunoassay Rapid Tests , by Region USD Million (2013-2018)
  • Table 22. Immunoassay Enzyme-Linked Immunospot , by Region USD Million (2013-2018)
  • Table 23. Immunoassay Western Blotting , by Region USD Million (2013-2018)
  • Table 24. Immunoassay Immuno-Pcr , by Region USD Million (2013-2018)
  • Table 25. Immunoassay Other , by Region USD Million (2013-2018)
  • Table 26. South America Immunoassay, by Country USD Million (2013-2018)
  • Table 27. South America Immunoassay, by Type USD Million (2013-2018)
  • Table 28. South America Immunoassay, by Application USD Million (2013-2018)
  • Table 29. South America Immunoassay, by Platform USD Million (2013-2018)
  • Table 30. South America Immunoassay, by Technology USD Million (2013-2018)
  • Table 31. Brazil Immunoassay, by Type USD Million (2013-2018)
  • Table 32. Brazil Immunoassay, by Application USD Million (2013-2018)
  • Table 33. Brazil Immunoassay, by Platform USD Million (2013-2018)
  • Table 34. Brazil Immunoassay, by Technology USD Million (2013-2018)
  • Table 35. Argentina Immunoassay, by Type USD Million (2013-2018)
  • Table 36. Argentina Immunoassay, by Application USD Million (2013-2018)
  • Table 37. Argentina Immunoassay, by Platform USD Million (2013-2018)
  • Table 38. Argentina Immunoassay, by Technology USD Million (2013-2018)
  • Table 39. Rest of South America Immunoassay, by Type USD Million (2013-2018)
  • Table 40. Rest of South America Immunoassay, by Application USD Million (2013-2018)
  • Table 41. Rest of South America Immunoassay, by Platform USD Million (2013-2018)
  • Table 42. Rest of South America Immunoassay, by Technology USD Million (2013-2018)
  • Table 43. Asia Pacific Immunoassay, by Country USD Million (2013-2018)
  • Table 44. Asia Pacific Immunoassay, by Type USD Million (2013-2018)
  • Table 45. Asia Pacific Immunoassay, by Application USD Million (2013-2018)
  • Table 46. Asia Pacific Immunoassay, by Platform USD Million (2013-2018)
  • Table 47. Asia Pacific Immunoassay, by Technology USD Million (2013-2018)
  • Table 48. China Immunoassay, by Type USD Million (2013-2018)
  • Table 49. China Immunoassay, by Application USD Million (2013-2018)
  • Table 50. China Immunoassay, by Platform USD Million (2013-2018)
  • Table 51. China Immunoassay, by Technology USD Million (2013-2018)
  • Table 52. Japan Immunoassay, by Type USD Million (2013-2018)
  • Table 53. Japan Immunoassay, by Application USD Million (2013-2018)
  • Table 54. Japan Immunoassay, by Platform USD Million (2013-2018)
  • Table 55. Japan Immunoassay, by Technology USD Million (2013-2018)
  • Table 56. India Immunoassay, by Type USD Million (2013-2018)
  • Table 57. India Immunoassay, by Application USD Million (2013-2018)
  • Table 58. India Immunoassay, by Platform USD Million (2013-2018)
  • Table 59. India Immunoassay, by Technology USD Million (2013-2018)
  • Table 60. South Korea Immunoassay, by Type USD Million (2013-2018)
  • Table 61. South Korea Immunoassay, by Application USD Million (2013-2018)
  • Table 62. South Korea Immunoassay, by Platform USD Million (2013-2018)
  • Table 63. South Korea Immunoassay, by Technology USD Million (2013-2018)
  • Table 64. Taiwan Immunoassay, by Type USD Million (2013-2018)
  • Table 65. Taiwan Immunoassay, by Application USD Million (2013-2018)
  • Table 66. Taiwan Immunoassay, by Platform USD Million (2013-2018)
  • Table 67. Taiwan Immunoassay, by Technology USD Million (2013-2018)
  • Table 68. Australia Immunoassay, by Type USD Million (2013-2018)
  • Table 69. Australia Immunoassay, by Application USD Million (2013-2018)
  • Table 70. Australia Immunoassay, by Platform USD Million (2013-2018)
  • Table 71. Australia Immunoassay, by Technology USD Million (2013-2018)
  • Table 72. Rest of Asia-Pacific Immunoassay, by Type USD Million (2013-2018)
  • Table 73. Rest of Asia-Pacific Immunoassay, by Application USD Million (2013-2018)
  • Table 74. Rest of Asia-Pacific Immunoassay, by Platform USD Million (2013-2018)
  • Table 75. Rest of Asia-Pacific Immunoassay, by Technology USD Million (2013-2018)
  • Table 76. Europe Immunoassay, by Country USD Million (2013-2018)
  • Table 77. Europe Immunoassay, by Type USD Million (2013-2018)
  • Table 78. Europe Immunoassay, by Application USD Million (2013-2018)
  • Table 79. Europe Immunoassay, by Platform USD Million (2013-2018)
  • Table 80. Europe Immunoassay, by Technology USD Million (2013-2018)
  • Table 81. Germany Immunoassay, by Type USD Million (2013-2018)
  • Table 82. Germany Immunoassay, by Application USD Million (2013-2018)
  • Table 83. Germany Immunoassay, by Platform USD Million (2013-2018)
  • Table 84. Germany Immunoassay, by Technology USD Million (2013-2018)
  • Table 85. France Immunoassay, by Type USD Million (2013-2018)
  • Table 86. France Immunoassay, by Application USD Million (2013-2018)
  • Table 87. France Immunoassay, by Platform USD Million (2013-2018)
  • Table 88. France Immunoassay, by Technology USD Million (2013-2018)
  • Table 89. Italy Immunoassay, by Type USD Million (2013-2018)
  • Table 90. Italy Immunoassay, by Application USD Million (2013-2018)
  • Table 91. Italy Immunoassay, by Platform USD Million (2013-2018)
  • Table 92. Italy Immunoassay, by Technology USD Million (2013-2018)
  • Table 93. United Kingdom Immunoassay, by Type USD Million (2013-2018)
  • Table 94. United Kingdom Immunoassay, by Application USD Million (2013-2018)
  • Table 95. United Kingdom Immunoassay, by Platform USD Million (2013-2018)
  • Table 96. United Kingdom Immunoassay, by Technology USD Million (2013-2018)
  • Table 97. Netherlands Immunoassay, by Type USD Million (2013-2018)
  • Table 98. Netherlands Immunoassay, by Application USD Million (2013-2018)
  • Table 99. Netherlands Immunoassay, by Platform USD Million (2013-2018)
  • Table 100. Netherlands Immunoassay, by Technology USD Million (2013-2018)
  • Table 101. Rest of Europe Immunoassay, by Type USD Million (2013-2018)
  • Table 102. Rest of Europe Immunoassay, by Application USD Million (2013-2018)
  • Table 103. Rest of Europe Immunoassay, by Platform USD Million (2013-2018)
  • Table 104. Rest of Europe Immunoassay, by Technology USD Million (2013-2018)
  • Table 105. MEA Immunoassay, by Country USD Million (2013-2018)
  • Table 106. MEA Immunoassay, by Type USD Million (2013-2018)
  • Table 107. MEA Immunoassay, by Application USD Million (2013-2018)
  • Table 108. MEA Immunoassay, by Platform USD Million (2013-2018)
  • Table 109. MEA Immunoassay, by Technology USD Million (2013-2018)
  • Table 110. Middle East Immunoassay, by Type USD Million (2013-2018)
  • Table 111. Middle East Immunoassay, by Application USD Million (2013-2018)
  • Table 112. Middle East Immunoassay, by Platform USD Million (2013-2018)
  • Table 113. Middle East Immunoassay, by Technology USD Million (2013-2018)
  • Table 114. Africa Immunoassay, by Type USD Million (2013-2018)
  • Table 115. Africa Immunoassay, by Application USD Million (2013-2018)
  • Table 116. Africa Immunoassay, by Platform USD Million (2013-2018)
  • Table 117. Africa Immunoassay, by Technology USD Million (2013-2018)
  • Table 118. North America Immunoassay, by Country USD Million (2013-2018)
  • Table 119. North America Immunoassay, by Type USD Million (2013-2018)
  • Table 120. North America Immunoassay, by Application USD Million (2013-2018)
  • Table 121. North America Immunoassay, by Platform USD Million (2013-2018)
  • Table 122. North America Immunoassay, by Technology USD Million (2013-2018)
  • Table 123. United States Immunoassay, by Type USD Million (2013-2018)
  • Table 124. United States Immunoassay, by Application USD Million (2013-2018)
  • Table 125. United States Immunoassay, by Platform USD Million (2013-2018)
  • Table 126. United States Immunoassay, by Technology USD Million (2013-2018)
  • Table 127. Canada Immunoassay, by Type USD Million (2013-2018)
  • Table 128. Canada Immunoassay, by Application USD Million (2013-2018)
  • Table 129. Canada Immunoassay, by Platform USD Million (2013-2018)
  • Table 130. Canada Immunoassay, by Technology USD Million (2013-2018)
  • Table 131. Mexico Immunoassay, by Type USD Million (2013-2018)
  • Table 132. Mexico Immunoassay, by Application USD Million (2013-2018)
  • Table 133. Mexico Immunoassay, by Platform USD Million (2013-2018)
  • Table 134. Mexico Immunoassay, by Technology USD Million (2013-2018)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Immunoassay: by Type(USD Million)
  • Table 146. Immunoassay Reagents and Kits , by Region USD Million (2019-2024)
  • Table 147. Immunoassay Analyzers , by Region USD Million (2019-2024)
  • Table 148. Immunoassay Software and Services , by Region USD Million (2019-2024)
  • Table 149. Immunoassay: by Application(USD Million)
  • Table 150. Immunoassay Infectious Disease , by Region USD Million (2019-2024)
  • Table 151. Immunoassay Endocrinology , by Region USD Million (2019-2024)
  • Table 152. Immunoassay Oncology , by Region USD Million (2019-2024)
  • Table 153. Immunoassay Cardiology , by Region USD Million (2019-2024)
  • Table 154. Immunoassay Hematology and Blood Screening , by Region USD Million (2019-2024)
  • Table 155. Immunoassay Autoimmune Disorders , by Region USD Million (2019-2024)
  • Table 156. Immunoassay Others , by Region USD Million (2019-2024)
  • Table 157. Immunoassay: by Platform(USD Million)
  • Table 158. Immunoassay Chemiluminescence Immunoassays , by Region USD Million (2019-2024)
  • Table 159. Immunoassay Fluorescence Immunoassays , by Region USD Million (2019-2024)
  • Table 160. Immunoassay Colorimetric Immunoassays , by Region USD Million (2019-2024)
  • Table 161. Immunoassay Radioimmunoassays , by Region USD Million (2019-2024)
  • Table 162. Immunoassay Other , by Region USD Million (2019-2024)
  • Table 163. Immunoassay: by Technology(USD Million)
  • Table 164. Immunoassay Enzyme-Linked Immunosorbent Assays , by Region USD Million (2019-2024)
  • Table 165. Immunoassay Rapid Tests , by Region USD Million (2019-2024)
  • Table 166. Immunoassay Enzyme-Linked Immunospot , by Region USD Million (2019-2024)
  • Table 167. Immunoassay Western Blotting , by Region USD Million (2019-2024)
  • Table 168. Immunoassay Immuno-Pcr , by Region USD Million (2019-2024)
  • Table 169. Immunoassay Other , by Region USD Million (2019-2024)
  • Table 170. South America Immunoassay, by Country USD Million (2019-2024)
  • Table 171. South America Immunoassay, by Type USD Million (2019-2024)
  • Table 172. South America Immunoassay, by Application USD Million (2019-2024)
  • Table 173. South America Immunoassay, by Platform USD Million (2019-2024)
  • Table 174. South America Immunoassay, by Technology USD Million (2019-2024)
  • Table 175. Brazil Immunoassay, by Type USD Million (2019-2024)
  • Table 176. Brazil Immunoassay, by Application USD Million (2019-2024)
  • Table 177. Brazil Immunoassay, by Platform USD Million (2019-2024)
  • Table 178. Brazil Immunoassay, by Technology USD Million (2019-2024)
  • Table 179. Argentina Immunoassay, by Type USD Million (2019-2024)
  • Table 180. Argentina Immunoassay, by Application USD Million (2019-2024)
  • Table 181. Argentina Immunoassay, by Platform USD Million (2019-2024)
  • Table 182. Argentina Immunoassay, by Technology USD Million (2019-2024)
  • Table 183. Rest of South America Immunoassay, by Type USD Million (2019-2024)
  • Table 184. Rest of South America Immunoassay, by Application USD Million (2019-2024)
  • Table 185. Rest of South America Immunoassay, by Platform USD Million (2019-2024)
  • Table 186. Rest of South America Immunoassay, by Technology USD Million (2019-2024)
  • Table 187. Asia Pacific Immunoassay, by Country USD Million (2019-2024)
  • Table 188. Asia Pacific Immunoassay, by Type USD Million (2019-2024)
  • Table 189. Asia Pacific Immunoassay, by Application USD Million (2019-2024)
  • Table 190. Asia Pacific Immunoassay, by Platform USD Million (2019-2024)
  • Table 191. Asia Pacific Immunoassay, by Technology USD Million (2019-2024)
  • Table 192. China Immunoassay, by Type USD Million (2019-2024)
  • Table 193. China Immunoassay, by Application USD Million (2019-2024)
  • Table 194. China Immunoassay, by Platform USD Million (2019-2024)
  • Table 195. China Immunoassay, by Technology USD Million (2019-2024)
  • Table 196. Japan Immunoassay, by Type USD Million (2019-2024)
  • Table 197. Japan Immunoassay, by Application USD Million (2019-2024)
  • Table 198. Japan Immunoassay, by Platform USD Million (2019-2024)
  • Table 199. Japan Immunoassay, by Technology USD Million (2019-2024)
  • Table 200. India Immunoassay, by Type USD Million (2019-2024)
  • Table 201. India Immunoassay, by Application USD Million (2019-2024)
  • Table 202. India Immunoassay, by Platform USD Million (2019-2024)
  • Table 203. India Immunoassay, by Technology USD Million (2019-2024)
  • Table 204. South Korea Immunoassay, by Type USD Million (2019-2024)
  • Table 205. South Korea Immunoassay, by Application USD Million (2019-2024)
  • Table 206. South Korea Immunoassay, by Platform USD Million (2019-2024)
  • Table 207. South Korea Immunoassay, by Technology USD Million (2019-2024)
  • Table 208. Taiwan Immunoassay, by Type USD Million (2019-2024)
  • Table 209. Taiwan Immunoassay, by Application USD Million (2019-2024)
  • Table 210. Taiwan Immunoassay, by Platform USD Million (2019-2024)
  • Table 211. Taiwan Immunoassay, by Technology USD Million (2019-2024)
  • Table 212. Australia Immunoassay, by Type USD Million (2019-2024)
  • Table 213. Australia Immunoassay, by Application USD Million (2019-2024)
  • Table 214. Australia Immunoassay, by Platform USD Million (2019-2024)
  • Table 215. Australia Immunoassay, by Technology USD Million (2019-2024)
  • Table 216. Rest of Asia-Pacific Immunoassay, by Type USD Million (2019-2024)
  • Table 217. Rest of Asia-Pacific Immunoassay, by Application USD Million (2019-2024)
  • Table 218. Rest of Asia-Pacific Immunoassay, by Platform USD Million (2019-2024)
  • Table 219. Rest of Asia-Pacific Immunoassay, by Technology USD Million (2019-2024)
  • Table 220. Europe Immunoassay, by Country USD Million (2019-2024)
  • Table 221. Europe Immunoassay, by Type USD Million (2019-2024)
  • Table 222. Europe Immunoassay, by Application USD Million (2019-2024)
  • Table 223. Europe Immunoassay, by Platform USD Million (2019-2024)
  • Table 224. Europe Immunoassay, by Technology USD Million (2019-2024)
  • Table 225. Germany Immunoassay, by Type USD Million (2019-2024)
  • Table 226. Germany Immunoassay, by Application USD Million (2019-2024)
  • Table 227. Germany Immunoassay, by Platform USD Million (2019-2024)
  • Table 228. Germany Immunoassay, by Technology USD Million (2019-2024)
  • Table 229. France Immunoassay, by Type USD Million (2019-2024)
  • Table 230. France Immunoassay, by Application USD Million (2019-2024)
  • Table 231. France Immunoassay, by Platform USD Million (2019-2024)
  • Table 232. France Immunoassay, by Technology USD Million (2019-2024)
  • Table 233. Italy Immunoassay, by Type USD Million (2019-2024)
  • Table 234. Italy Immunoassay, by Application USD Million (2019-2024)
  • Table 235. Italy Immunoassay, by Platform USD Million (2019-2024)
  • Table 236. Italy Immunoassay, by Technology USD Million (2019-2024)
  • Table 237. United Kingdom Immunoassay, by Type USD Million (2019-2024)
  • Table 238. United Kingdom Immunoassay, by Application USD Million (2019-2024)
  • Table 239. United Kingdom Immunoassay, by Platform USD Million (2019-2024)
  • Table 240. United Kingdom Immunoassay, by Technology USD Million (2019-2024)
  • Table 241. Netherlands Immunoassay, by Type USD Million (2019-2024)
  • Table 242. Netherlands Immunoassay, by Application USD Million (2019-2024)
  • Table 243. Netherlands Immunoassay, by Platform USD Million (2019-2024)
  • Table 244. Netherlands Immunoassay, by Technology USD Million (2019-2024)
  • Table 245. Rest of Europe Immunoassay, by Type USD Million (2019-2024)
  • Table 246. Rest of Europe Immunoassay, by Application USD Million (2019-2024)
  • Table 247. Rest of Europe Immunoassay, by Platform USD Million (2019-2024)
  • Table 248. Rest of Europe Immunoassay, by Technology USD Million (2019-2024)
  • Table 249. MEA Immunoassay, by Country USD Million (2019-2024)
  • Table 250. MEA Immunoassay, by Type USD Million (2019-2024)
  • Table 251. MEA Immunoassay, by Application USD Million (2019-2024)
  • Table 252. MEA Immunoassay, by Platform USD Million (2019-2024)
  • Table 253. MEA Immunoassay, by Technology USD Million (2019-2024)
  • Table 254. Middle East Immunoassay, by Type USD Million (2019-2024)
  • Table 255. Middle East Immunoassay, by Application USD Million (2019-2024)
  • Table 256. Middle East Immunoassay, by Platform USD Million (2019-2024)
  • Table 257. Middle East Immunoassay, by Technology USD Million (2019-2024)
  • Table 258. Africa Immunoassay, by Type USD Million (2019-2024)
  • Table 259. Africa Immunoassay, by Application USD Million (2019-2024)
  • Table 260. Africa Immunoassay, by Platform USD Million (2019-2024)
  • Table 261. Africa Immunoassay, by Technology USD Million (2019-2024)
  • Table 262. North America Immunoassay, by Country USD Million (2019-2024)
  • Table 263. North America Immunoassay, by Type USD Million (2019-2024)
  • Table 264. North America Immunoassay, by Application USD Million (2019-2024)
  • Table 265. North America Immunoassay, by Platform USD Million (2019-2024)
  • Table 266. North America Immunoassay, by Technology USD Million (2019-2024)
  • Table 267. United States Immunoassay, by Type USD Million (2019-2024)
  • Table 268. United States Immunoassay, by Application USD Million (2019-2024)
  • Table 269. United States Immunoassay, by Platform USD Million (2019-2024)
  • Table 270. United States Immunoassay, by Technology USD Million (2019-2024)
  • Table 271. Canada Immunoassay, by Type USD Million (2019-2024)
  • Table 272. Canada Immunoassay, by Application USD Million (2019-2024)
  • Table 273. Canada Immunoassay, by Platform USD Million (2019-2024)
  • Table 274. Canada Immunoassay, by Technology USD Million (2019-2024)
  • Table 275. Mexico Immunoassay, by Type USD Million (2019-2024)
  • Table 276. Mexico Immunoassay, by Application USD Million (2019-2024)
  • Table 277. Mexico Immunoassay, by Platform USD Million (2019-2024)
  • Table 278. Mexico Immunoassay, by Technology USD Million (2019-2024)
  • Table 279. Research Programs/Design for This Report
  • Table 280. Key Data Information from Secondary Sources
  • Table 281. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunoassay: by Type USD Million (2013-2018)
  • Figure 5. Global Immunoassay: by Application USD Million (2013-2018)
  • Figure 6. Global Immunoassay: by Platform USD Million (2013-2018)
  • Figure 7. Global Immunoassay: by Technology USD Million (2013-2018)
  • Figure 8. South America Immunoassay Share (%), by Country
  • Figure 9. Asia Pacific Immunoassay Share (%), by Country
  • Figure 10. Europe Immunoassay Share (%), by Country
  • Figure 11. MEA Immunoassay Share (%), by Country
  • Figure 12. North America Immunoassay Share (%), by Country
  • Figure 13. Global Immunoassay share by Players 2018 (%)
  • Figure 14. Global Immunoassay share by Players (Top 3) 2018(%)
  • Figure 15. Global Immunoassay share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2018
  • Figure 21. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Siemens Healthineers (Germany) Revenue: by Geography 2018
  • Figure 23. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson and Company (United States) Revenue: by Geography 2018
  • Figure 25. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Danaher Corporation (United States) Revenue: by Geography 2018
  • Figure 27. BioMérieux Inc. (France) Revenue, Net Income and Gross profit
  • Figure 28. BioMérieux Inc. (France) Revenue: by Geography 2018
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 31. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2018
  • Figure 33. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Sysmex Corporation (Japan) Revenue: by Geography 2018
  • Figure 35. Abcam plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Abcam plc. (United Kingdom) Revenue: by Geography 2018
  • Figure 37. Global Immunoassay: by Type USD Million (2019-2024)
  • Figure 38. Global Immunoassay: by Application USD Million (2019-2024)
  • Figure 39. Global Immunoassay: by Platform USD Million (2019-2024)
  • Figure 40. Global Immunoassay: by Technology USD Million (2019-2024)
  • Figure 41. South America Immunoassay Share (%), by Country
  • Figure 42. Asia Pacific Immunoassay Share (%), by Country
  • Figure 43. Europe Immunoassay Share (%), by Country
  • Figure 44. MEA Immunoassay Share (%), by Country
  • Figure 45. North America Immunoassay Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Bio-Rad Laboratories, Inc. (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Siemens Healthineers (Germany)
  • Becton, Dickinson and Company (United States)
  • Danaher Corporation (United States)
  • bioMérieux Inc. (France)
  • Abbott Laboratories (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Sysmex Corporation (Japan)
  • Abcam plc. (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation